» Articles » PMID: 23580580

Reply to "The Dual Personality of Iron Chelators: Growth Inhibitors or Promoters?"

Overview
Specialty Pharmacology
Date 2013 Apr 13
PMID 23580580
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection.

Thompson M, Truong-Le V, Alamneh Y, Black C, Anderl J, Honnold C Antimicrob Agents Chemother. 2015; 59(10):6484-93.

PMID: 26239978 PMC: 4576086. DOI: 10.1128/AAC.00882-15.

References
1.
Visca P, Bonchi C, Minandri F, Frangipani E, Imperi F . The dual personality of iron chelators: growth inhibitors or promoters?. Antimicrob Agents Chemother. 2013; 57(5):2432-3. PMC: 3632938. DOI: 10.1128/AAC.02529-12. View

2.
Moreau-Marquis S, OToole G, Stanton B . Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol. 2009; 41(3):305-13. PMC: 2742750. DOI: 10.1165/rcmb.2008-0299OC. View

3.
Banin E, Brady K, Greenberg E . Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol. 2006; 72(3):2064-9. PMC: 1393226. DOI: 10.1128/AEM.72.3.2064-2069.2006. View

4.
Thompson M, Corey B, Si Y, Craft D, Zurawski D . Antibacterial activities of iron chelators against common nosocomial pathogens. Antimicrob Agents Chemother. 2012; 56(10):5419-21. PMC: 3457357. DOI: 10.1128/AAC.01197-12. View

5.
Kuehn B . Scientists seek antibiotic adjuvants. JAMA. 2011; 306(20):2203-4. DOI: 10.1001/jama.2011.1709. View